The business community has urged the government to take notice of Panadol shortage in the market which is causing problems for the doctors and patients amidst malaria and dengue.
The ICCI President Mr. Ahsan Zafar Bakhtawari has requested the government to resolve the issue of Panadol’s availability in the market on immediate bases. The shortage of medicine is already impacting pharmacies and medical practitioners.
Bakhtawari was talking to a delegation from Pakistan Chemists and Druggists Association (PCDA) under the leadership of Mian Tariq Saeed. During the meeting he said that Panadol’s demand is increasing in the market, especially in the flood-affected areas and after the dengue and malaria outbreak. The shortage of this drug has now started affecting the patients and their health.
Bakhtawari said, “The manufacturer has suspended the production of Panadol due to a twofold increase in the price of its raw material. They are urging that the government take urgent measures to rationalize the price of raw material to ensure a restart of its production and easy availability in the market.”
The PCDA Chairman said, “The price of raw materials required to produce Panadol has witnessed a twofold increase which affected the availability of this product in the market and pharmacies are also losing business on this account,” urging the government to look into the root cause of this shortage.
“The online buying and selling of medicines are illegal under the Drug Act. The regulator should ensure strict implementation of this law as this practice was affecting the businesses of license holder chemists and druggists,” he said.
Want to add something to this story? Let us know in the comments section.
